Get the Stockscreener App
0.659
3.09%
-0.021
iBio Inc stock is traded at $0.659, with a volume of 370.21K.
It is down -3.09% in the last 24 hours and down -12.12% over the past month.
iBio, Inc., a biotechnology company, provides product development and manufacturing services to clients, collaborators, and third-party customers in the United States and internationally. The company's services cover the stages of product selection, regulatory approval, and commercial product launch. Its lead therapeutic candidate is IBIO-CFB03 for the treatment of systemic scleroderma, idiopathic pulmonary fibrosis, and other fibrotic diseases. It is also developing vaccine candidates for third parties. The company has collaboration agreements with ONEWAY Diagnostica; AzarGen Biotechnologies (Pty) Ltd; The Texas A&M University System; and Fraunhofer Center for Molecular Biotechnology, as well as strategic relationship with CC-Pharming Ltd. In addition, it offers a range of product and process development, analytical, and manufacturing services. iBio, Inc. is headquartered in New York, New York.
See More
Previous Close:
$0.68
Open:
$0.68
24h Volume:
370.21K
Relative Volume:
0.17
Market Cap:
$10.69M
Revenue:
$2.05M
Net Income/Loss:
$-23.15M
P/E Ratio:
-0.0994
EPS:
-6.6319
Net Cash Flow:
$-16.93M
1W Performance:
-10.11%
1M Performance:
-12.12%
6M Performance:
-78.11%
1Y Performance:
-68.01%
1-Day Range:
$0.6479
$0.6922
1-Week Range:
$0.6479
$0.7301
52-Week Range:
$0.6358
$6.8908
iBio Inc Stock (IBIO) Company Profile
Name
iBio Inc
Sector
Industry
Phone
302-355-0650
Address
600 Madison Avenue, Suite 1601, New York, NY
Compare IBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IBIO
iBio Inc
|
0.659 | 11.03M | 2.05M | -23.15M | -16.93M | -6.6319 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
iBio Inc Stock (IBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-28-24 | Initiated | Chardan Capital Markets | Buy |
| Nov-29-21 | Initiated | JMP Securities | Mkt Outperform |
| Jan-22-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-26-20 | Initiated | Alliance Global Partners | Buy |
iBio Inc Stock (IBIO) Latest News
iBio Faces Nasdaq Delisting Notice for Stock Price - TipRanks
iBio receives Nasdaq notice for minimum bid price deficiency By Investing.com - Investing.com South Africa
iBio receives Nasdaq notice for minimum bid price deficiency - Investing.com
What are analysts’ price targets for iBio Inc. in the next 12 monthsEarnings Report Opportunities To Watch Now - jammulinksnews.com
What institutional investors are buying iBio Inc. stockSwing Trade Entry Points For Fast Growth - jammulinksnews.com
Will earnings trigger a reversal in iBio Inc.High Confidence Strategy with Trend Alignment - Newser
Can iBio Inc. Rally Enough to Break EvenLong Hold Safe Return Strategy Reviewed - metal.it
Why iBio Inc. stock attracts strong analyst attentionROI Driven Equity Selection With Safety Emphasized - metal.it
Ichimoku Cloud Indicates Uncertainty Around iBio Inc.Quick Gain Stock Watch With Indicators Reviewed - metal.it
Identifying reversal signals in iBio Inc.Investment Roadmap for High Potential Stocks - Newser
What institutions are buying iBio Inc. stock nowRisk-Managed Trade Alerts for Consistency - Newser
Full technical analysis of iBio Inc. stockFree Low Risk Picks for Daily Trading - Newser
What makes iBio Inc. stock price move sharplyReal-Time Market Sentiment Tracking Gains Momentum - metal.it
Will iBio Inc. bounce back from current supportMomentum Prediction Based on AI Backtesting - Newser
How does iBio Inc. generate profit in a changing economyHigh-performance investment picks - jammulinksnews.com
What are the technical indicators suggesting about iBio Inc.Record-breaking capital gains - jammulinksnews.com
What makes iBio Inc. stock price move sharply AI Stock Movement Forecast with Accuracy - metal.it
How volatile is iBio Inc. stock compared to the marketMaximize your gains with expert trading tips - jammulinksnews.com
How strong is IBIO company’s balance sheetCapitalize on emerging industry trends - jammulinksnews.com
iBio Inc. Company Revenue and Profit Trends: A Deep DiveFree Stock Market Practical Discussion Forums - Newser
iBio Inc. Stock Support and Resistance Levels You Should KnowLow Drawdown Trade Signals - Newser
iBio Inc. Stock Analysis and ForecastConsistently superior profits - PrintWeekIndia
What analysts say about iBio Inc. stockFree Investment Timing Strategies - Autocar Professional
What drives iBio Inc. stock priceSkyrocketing profit margins - Autocar Professional
Is iBio Inc. a good long term investmentExplosive earning power - jammulinksnews.com
how ibio stock performs during market volatilityFree Short-Term Stock Picks - Newser
what makes ibio inc. stock price move sharplyFree Step-by-Step Investment Guide - Newser
iBio Inc Stock (IBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):